ASX-listed anti-ageing and hair loss treatment business Anagenics said its chief executive Maria Halasz resigned on Monday in an announcement that failed to declare either thanks or praise for her 15 years in the role. Shares in the business are down around 90 per cent since the start of 2018.

The resignation came the same day Ms Halasz’s lawyer answered questions from The Australian Financial Review over Anagenics’ April 2021 deal to sell all the shares in its biotech subsidiary Lyramid to a mysterious Panamanian holding company named Provelmare Holding SA.